Back
Aytu BioPharma 10K Form
Sell
40
AYTU
Aytu BioPharma
Last Price:
2.35
Seasonality Move:
78.97%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AYTU News And Ratings
See the #1 stock for the next 7 days that we like better than AYTU
AYTU Financial Statistics
Sales & Book Value
| Annual Sales: | $81M |
|---|---|
| Cash Flow: | $-788K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.64 |
| Price / Book: | 0.51 |
Profitability
| EPS (TTM): | -2.86000 |
|---|---|
| Net Income (TTM): | $-15.84M |
| Gross Margin: | $54.59M |
| Return on Equity: | -48.64% |
| Return on Assets: | -12.23% |
Aytu BioPharma Earnings Forecast
Key Aytu BioPharma Financial Ratios
- The Gross Profit Margin over the past 18 years for AYTU is 67.39%.
- The Selling, General & Administrative Expenses for AYTU have been equal to 61.08% of Gross Profit Margin.
- The Research & Development expenses have been 3.45% of Revenue.
- The Interest Expense is -30.24% of Operating Income.
- The Net Earning history of AYTU is -19.56% of Total Revenues.
- Per Share Earnings over the last 18 years have been positive in 7 years.
Aytu BioPharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | AYTU |
| CUSIP: | 054754 |
| Website: | aytubio.com |
Debt
| Debt-to-Equity Ratio: | 0.55 |
|---|---|
| Current Ratio: | 0.99 |
| Quick Ratio: | 0.7 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
AYTU Technical Analysis vs Fundamental Analysis
Sell
40
Aytu BioPharma (AYTU)
is a Sell
Is Aytu BioPharma a Buy or a Sell?
-
Aytu BioPharma stock is rated a Sell
The current Aytu BioPharma [AYTU] share price is $2.36. The Score for AYTU is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.